No Data
No Data
Is Royalty Pharma Plc (RPRX) The Best Defensive Stock Amid Market Volatility?
Unusual Options Activity: AZN, FOUR and Others Attract Market Bets, AZN V/OI Ratio Reaches 272.7
EST Mar 25th Closing Delivery - In the last three hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options
These 4 Measures Indicate That Royalty Pharma (NASDAQ:RPRX) Is Using Debt Extensively
Royalty Pharma's Strong Portfolio and Future Growth Potential Underpin Buy Rating
Royalty Pharma to Present at TD Cowen's 45th Annual Health Care Conference
Peering Into Royalty Pharma's Recent Short Interest